FDA Classifies Computerized Behavioral Therapy Device for Fibromyalgia Symptoms as Class II

The Food and Drug Administration (FDA) has classified the computerized behavioral therapy device for the treatment of fibromyalgia symptoms into Class II (special controls). This action aims to provide reasonable assurance of the device's safety and effectiveness and enhance patient access to beneficial innovative devices by reducing regulatory burdens.